Sarcopenia and cardiovascular diseases
AA Damluji, M Alfaraidhy, N AlHajri, NN Rohant… - Circulation, 2023 - Am Heart Assoc
Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
JA Batsis, DT Villareal - Nature Reviews Endocrinology, 2018 - nature.com
The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle
mass and strength or physical function) is increasing in adults aged 65 years and older. A …
mass and strength or physical function) is increasing in adults aged 65 years and older. A …
Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline
S Bhasin, JP Brito, GR Cunningham… - The Journal of …, 2018 - academic.oup.com
Abstract Objective To update the “Testosterone Therapy in Men With Androgen Deficiency
Syndromes” guideline published in 2010. Participants The participants include an Endocrine …
Syndromes” guideline published in 2010. Participants The participants include an Endocrine …
Evaluation and management of testosterone deficiency: AUA guideline
JP Mulhall, LW Trost, RE Brannigan, EG Kurtz… - The Journal of …, 2018 - auajournals.org
Purpose: There has been a marked increase in testosterone prescriptions in the past
decade resulting in a growing need to give practicing clinicians proper guidance on the …
decade resulting in a growing need to give practicing clinicians proper guidance on the …
Health consequences of sarcopenic obesity: a narrative review
E Roh, KM Choi - Frontiers in endocrinology, 2020 - frontiersin.org
Sarcopenia is defined as the age-related loss of muscle mass and strength or physical
performance. Increased amounts of adipose tissue often accompany sarcopenia, a condition …
performance. Increased amounts of adipose tissue often accompany sarcopenia, a condition …
Effects of testosterone treatment in older men
PJ Snyder, S Bhasin, GR Cunningham… - … England Journal of …, 2016 - Mass Medical Soc
Background Serum testosterone concentrations decrease as men age, but benefits of
raising testosterone levels in older men have not been established. Methods We assigned …
raising testosterone levels in older men have not been established. Methods We assigned …
Muscle wasting in disease: molecular mechanisms and promising therapies
S Cohen, JA Nathan, AL Goldberg - Nature reviews Drug discovery, 2015 - nature.com
Atrophy occurs in specific muscles with inactivity (for example, during plaster cast
immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle …
immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle …
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
J Hudson, M Cruickshank, R Quinton… - The Lancet Healthy …, 2022 - thelancet.com
Background Testosterone is the standard treatment for male hypogonadism, but there is
uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide …
uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide …
Testosterone treatment and coronary artery plaque volume in older men with low testosterone
MJ Budoff, SS Ellenberg, CE Lewis, ER Mohler… - Jama, 2017 - jamanetwork.com
Importance Recent studies have yielded conflicting results as to whether testosterone
treatment increases cardiovascular risk. Objective To test the hypothesis that testosterone …
treatment increases cardiovascular risk. Objective To test the hypothesis that testosterone …
A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans
JE Morley, TK Malmstrom, DK Miller - The journal of nutrition, health & …, 2012 - Springer
Objective To validate the FRAIL scale. Design Longitudinal study. Setting Community.
Participants Representative sample of African Americans age 49 to 65 years at onset of …
Participants Representative sample of African Americans age 49 to 65 years at onset of …